/KALY
KALY Stock - Kali, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for KALY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-72.35
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2018 | FY2017 | FY2016 | FY2015 | FY2012 |
|---|---|---|---|---|---|
| Revenue | $65,265 | $67,590 | $71,544 | $83,618 | $94.55M |
| Gross Profit | $14,364 | $18,640 | $1,353 | $83,618 | $42.06M |
| Gross Margin | 22.0% | 27.6% | 1.9% | 100.0% | 44.5% |
| Operating Income | $-11,900 | $-9,310 | $1,350 | $-5,130 | $24.14M |
| Net Income | $-11,903 | $-9,310 | $1,353 | $-5,131 | $17.52M |
| Net Margin | -18.2% | -13.8% | 1.9% | -6.1% | 18.5% |
| EPS | $-0.00 | $-0.00 | $0.00 | $-0.00 | $6.83 |
Company Overview
Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. It provides pharmaceuticals, cannabis extracts, and health and wellness products. The company was formerly known as VLOV Inc. and changed its name to Kali, Inc. in February 2016. Kali, Inc. is based in Dallas, Texas.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
KALYBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$2.13
Q1 2013
EPS Surprise History
Q2 11
No data
Q3 11
No data
Q4 11
No data
Q1 12
No data
Q2 12
No data
Q3 12
No data
Q4 12
No data
Q1 13
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2019 | Nov 27, 2019 | — | — | — | — |
Q1 2013 | Mar 31, 2013 | — | $2.13 | — | — |
Q4 2012 | Dec 31, 2012 | — | $2.81 | — | — |
Q3 2012 | Sep 30, 2012 | — | $1.15 | — | — |
Q2 2012 | Jun 30, 2012 | — | $1.86 | — | — |
Q1 2012 | Mar 31, 2012 | — | $0.95 | — | — |
Q4 2011 | Dec 31, 2011 | — | $1.58 | — | — |
Q3 2011 | Sep 30, 2011 | — | $0.62 | — | — |
Q2 2011 | Jun 30, 2011 | — | $1.45 | — | — |
Q1 2011 | Mar 31, 2011 | — | $1.71 | — | — |
Q4 2010 | Dec 31, 2010 | — | $2.15 | — | — |
Q3 2010 | Sep 30, 2010 | — | $1.32 | — | — |
Q2 2010 | Jun 30, 2010 | — | $1.67 | — | — |
Q1 2010 | Mar 31, 2010 | — | $0.40 | — | — |
Q4 2009 | Dec 31, 2009 | — | $0.74 | — | — |
Q3 2009 | Sep 30, 2009 | — | $1.28 | — | — |
Q2 2009 | Jun 30, 2009 | — | $1.08 | — | — |
Q1 2009 | Mar 31, 2009 | — | $1.85 | — | — |
Q4 2008 | Nov 30, 2008 | — | $-1.63 | — | — |
Q3 2008 | Aug 31, 2008 | — | $-0.37 | — | — |
Latest News
Loading news...
Frequently Asked Questions about KALY
What is KALY's current stock price?
Kali, Inc. (KALY) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for KALY?
No analyst price targets are currently available for this stock.
What sector is Kali, Inc. in?
Kali, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is KALY's market cap?
Kali, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does KALY pay dividends?
No, Kali, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACUR
Acura Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
AZFL
Amazonas Florestal, Ltd
$0.00
Mkt Cap: $0.0B
CBDX
Curative Biosciences, Inc.
$0.00
Mkt Cap: $0.0B
CNNC
Cannonau Corp.
$0.00
Mkt Cap: $0.0B
FLHLF
Filament Health Corp.
$0.00
Mkt Cap: $0.0B
GMVDF
G Medical Innovations Holdings Ltd
$0.00
Mkt Cap: $0.0B
GNLKQ
GeneLink, Inc.
$0.00
Mkt Cap: $0.0B
MRRCF
Wayland Group Corp.
$0.00
Mkt Cap: $0.0B
NNRX
Nutranomics, Inc.
$0.00
Mkt Cap: $0.0B
TNPH
Tian'an Pharmaceutical Co., Ltd.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to KALY for comparison